New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 9, 2012
12:35 EDTDGX, MMMQuest Diagnostics unit, 3M say FDA gives clearance for Simplexa test
Focus Diagnostics, a business of Quest Diagnostics (DGX), and 3M (MMM) announced that the U.S. Food and Drug Administration has provided 510(k) clearance and CLIA moderate-complexity categorization to the Simplexa Flu A/B & RSV Direct test on the 3M Integrated Cycler. The new test aids in the qualitative detection and differentiation of RNA of influenza A and B viruses and respiratory syncytial virus, common causes of respiratory illness. The Simplexa Flu A/B & RSV Direct is now available in the United States. It was CE marked for distribution in Europe in 2011.
News For DGX;MMM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 24, 2014
16:16 EDTMMM3M Company initiated with an Underperform at RBC Capital
Subscribe for More Information
06:45 EDTMMMTyco downgraded to Market Perform from Outperform at FBR Capital
Subscribe for More Information
November 19, 2014
10:21 EDTDGXHigh option volume stocks
Subscribe for More Information
November 17, 2014
07:16 EDTDGXMilken Institute--Faster Cures to hold a conference
Subscribe for More Information
November 14, 2014
07:14 EDTDGXAmerican College of Rheumatology is holding a meeting
2014 ACR/ARHP Annual Meeting is being held in Boston on November 14-19.
November 13, 2014
11:03 EDTMMM3M Company targets R&D investment of approximately 6% by 2017
3M Company is focused on investment in R&D and not yet on margin expansion. Comment made at Goldman Sachs Industrials Conference 2014.
10:01 EDTDGXOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:16 EDTDGXLabCorp downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank downgraded LabCorp (LH) to Hold saying revenue synergies from the Covance (CVD) acquisition are "hard to envision." The firm believes LabCorp is now less of a pure play in the Clinical Labs space and lowered its price target for shares to $115 from $120. Deutsche coupled the downgrade with an upgrade of peer Quest (DGX).
06:13 EDTDGXQuest Diagnostics upgraded to Buy from Hold at Deutsche Bank
Subscribe for More Information
November 12, 2014
08:05 EDTMMMGoldman to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use